Picamilon (sodium)

Picamilon sodium is an orally active derivative of γ-aminobutyric acid that has nootropic effect. Picamilon sodium improves the epilepsy model in rats and promotes correction of functional disorders of the pancreas during Alloxan (HY-W017227) -induced diabetes mellitus in rats[1][2][3].

Product Specifications

CAS Number

[62936-56-5]

Product Name Alternative

Nicotinoyl-GABA (sodium) ; Nicotinoyl-γ-aminobutyric acid (sodium) ; Sodium 4- (nicotinamido) butanoate

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

GABA Receptor

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/picamilon-sodium.html

Purity

97.0

Smiles

[Na].O=C(O)CCCNC(=O)C=1C=NC=CC1

Molecular Formula

C10H11N2NaO3

Molecular Weight

231.21

Precautions

H302, H315, H319, H335

References & Citations

[1]Mirzoian RS, et al. Vliianie pikamilona na krovosnabzhenie kory i mikrotsirkuliatsiiu v sisteme pial'nykh arteriol [Effect of pikamilon on the cortical blood supply and microcirculation in the pial arteriole system]. Biull Eksp Biol Med. 1989 May;107 (5) :581-2. Russian. |[2]Denisenko, et al. Effects of Picamilon and Isopicamilon on the Formation of Picrotoxin-Induced Convulsive Activity in Rats. Neurophysiology 46, 284–287 (2014) .